Literature DB >> 16634926

Ocular lesions in Watanabe heritable hyperlipidemic rabbits.

Mami Kouchi1, Yoshinaka Ueda, Hiroshi Horie, Kohji Tanaka.   

Abstract

Hyperlipidemic ocular lesions are described for Watanabe heritable hyperlipidemic (WHHL) rabbits. Male WHHL rabbits 8 months old exhibited serum hyperlipidemia and ophthalmoscopically yellowish-white lesions along the corneoscleral junction and in the iris. Histopathologically, foamy macrophages aggregated in the stroma of the cornea, iris, and ciliary body were observed. These findings have been interpreted as lipid keratopathy. In addition, multiple clusters of a large number of foamy macrophages occurred throughout the choroid and sclera in association with the blood vessels. The lesions in the choroid and sclera could not be detected ophthalmoscopy, yet were much more prominent than those in the cornea, iris, and ciliary body, suggesting greater involvement and earlier onset of lipidosis at these sites associated with hyperlipidemia in WHHL rabbits.

Entities:  

Mesh:

Year:  2006        PMID: 16634926     DOI: 10.1111/j.1463-5224.2006.00453.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  3 in total

Review 1.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

2.  Glaucoma in a New Zealand White Rabbit Fed High-cholesterol Diet.

Authors:  Emi Kashiwagi; Koichi Masuno; Kae Fujisawa; Shuuichi Matsushima; Mikinori Torii; Nobuo Takasu
Journal:  J Toxicol Pathol       Date:  2012-03       Impact factor: 1.628

3.  The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease.

Authors:  Masashi Shiomi
Journal:  J Atheroscler Thromb       Date:  2019-11-21       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.